Skip to main content

NCT00269815 - Long-term Safety and Effectiveness of OROS (Methylphenidate HCl) in Children With ADHD

Long-term Safety and Effectiveness of OROS (Methylphenidate HCl) in Children With ADHD


Data Specification

Available upon data request approval


Annotated CRF

Available upon data request approval

Product Info

Generic Name
Methylphenidate HCl
Product Name
CONCERTA®
Therapeutic Area
Behaviors and Mental Disorders
Enrollment
436
% Female
17.0%
% White
86.0%
Product Class
Stimulants/ADHD/Anorexiants
Sponsor Protocol Number
C98012
Data Partner
Johnson & Johnson
Condition Studied
Attention Deficit Hyperactivity Disorder
Mean/Median Age (Years)
9.2

Supporting Documentation

Collected Datasets
Data Definition Specification
Annotated Case Report Form
Study Phase 
3

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.